在主导光学缩中OPA1表达的CRISPRa介导的增加
Giada Becchi1, Michael Whitehead1, Joshua P Harvey1
1UCL Institute of Ophthalmology, Faculty of Brain Sciences, London EC1V 9EL, UK.
International journal of molecular sciences
|July 12, 2025
概括
克里斯普尔激活 (CRISPRa) 显示出对治疗主导视力缩 (DOA),一种常见的遗传性视力神经病变的希望. 这种基因治疗方法成功地恢复了OPA1基因表达,并在DOA的细胞模型中改善了线粒体功能.
科学领域:
- 遗传学和分子生物学
- 眼科医生 眼科 眼科
- 基因治疗 基因治疗
背景情况:
- 主导性视力缩 (DOA) 是最常见的遗传性视力神经病变,其特点是由于视网膜质细胞 (RGC) 退化而逐渐失去视力.
- 对于线粒体融合至关重要的OPA1基因的致病变体占DOA病例的60%以上,目前没有可用的治疗选择.
- 现有的细胞模型显示减少了OPA1mRNA,OPA1蛋白和线粒体网络异常,反映了DOA病理.
研究的目的:
- 评估CRISPR激活 (CRISPRa) 对主导光学缩 (DOA) 的治疗潜力.
- 建立一个体外DOA模型,使用同质导向修复引入一个常见的OPA1病原型.
- 在DOA模型中评估CRISPRa在恢复OPA1表达和减轻与疾病相关的表型方面的有效性.
主要方法:
- 在HEK293T细胞中通过引入c.2708_2711TTAGdel OPA1致病变体使用同质导向修复,创建了体外DOA模型.
- 采用CRISPR激活 (CRISPRa),利用dCas9-VPR融合蛋白和指导RNA (gRNAs) 准OPA1基因促进体.
- 在CRISPRa治疗后分析了Opa1表达水平 (mRNA和蛋白质),OPA1异型比率和线粒体网络形态.
主要成果:
- 克里斯普拉,特别是使用gRNA3和dCas9-VPR,显著增加了OPA1mRNA和蛋白质水平,接近对照细胞的水平.
- 克里斯普拉治疗成功地保持了OPA1异形转录的正确比例,这对于适当的线粒体功能至关重要.
- 用CRISPRa治疗的细胞表现出改善的线粒体网络结构,这表明疾病相关的表型的部分救援.
结论:
- 克里斯普尔激活显示出作为主导光学缩 (DOA) 的治疗策略的巨大潜力.
- 这项研究验证了CRISPRa在DOA细胞模型中恢复OPA1表达和改善线粒体功能障碍的能力.
- 对基于CRISPRa的治疗方法的进一步研究可能为患有DOA的患者提供一种新的治疗途径.
相关概念视频
Glaucoma: Overview
775
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
775
Open Angle Glaucoma: Treatment
579
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
579
Angle Closure Glaucoma: Treatment
697
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
697
Photoreceptors and Visual Pathways
6.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.5K


